Cargando…
Ribonuclease 1 Enhances Antitumor Immunity against Breast Cancer by Boosting T cell Activation
The secretory enzyme human ribonuclease 1 (RNase1) is involved in innate immunity and anti-inflammation, achieving host defense and anti-cancer effects; however, whether RNase1 contributes to adaptive immune response in the tumor microenvironment (TME) remains unclear. Here, we established a syngene...
Autores principales: | Wang, Ying-Nai, Lee, Heng-Huan, Jiang, Zhou, Chan, Li-Chuan, Hortobagyi, Gabriel N., Yu, Dihua, Hung, Mien-Chie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10321278/ https://www.ncbi.nlm.nih.gov/pubmed/37416781 http://dx.doi.org/10.7150/ijbs.84592 |
Ejemplares similares
-
A novel ligand-receptor relationship between families of ribonucleases and receptor tyrosine kinases
por: Wang, Ying-Nai, et al.
Publicado: (2018) -
Human ribonuclease 1 serves as a secretory ligand of ephrin A4 receptor and induces breast tumor initiation
por: Lee, Heng-Huan, et al.
Publicado: (2021) -
The impact of PD-L1 N-linked glycosylation on cancer therapy and clinical diagnosis
por: Wang, Ying-Nai, et al.
Publicado: (2020) -
Ephrin receptor A10 monoclonal antibodies and the derived chimeric antigen receptor T cells exert an antitumor response in mouse models of triple-negative breast cancer
por: Cha, Jong-Ho, et al.
Publicado: (2022) -
CDK4/6 inhibitors in hormone receptor-positive, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: Are we at the finish line?
por: Yam, Clinton, et al.
Publicado: (2018)